Clinical Trial Update: Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating letrozole with tipifarnib versus placebo in advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Tipifarnib (tipifarnib)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED